| Primary |
| Chronic Obstructive Pulmonary Disease |
31.6% |
| Hypertension |
13.7% |
| Asthma |
7.0% |
| Prophylaxis |
5.8% |
| Anxiety |
5.4% |
| Supplementation Therapy |
4.5% |
| Blood Cholesterol Increased |
4.2% |
| Bronchitis Chronic |
3.8% |
| Gastrooesophageal Reflux Disease |
3.8% |
| Emphysema |
3.2% |
| Hypothyroidism |
2.9% |
| Cardiac Disorder |
2.2% |
| Pain |
2.2% |
| Atrial Fibrillation |
1.9% |
| Diabetes Mellitus |
1.9% |
| Back Pain |
1.3% |
| Depression |
1.3% |
| Vitamin Supplementation |
1.3% |
| Abdominal Discomfort |
1.0% |
| Dyspnoea |
1.0% |
|
| Product Quality Issue |
22.2% |
| Incorrect Route Of Drug Administration |
13.0% |
| Oropharyngeal Pain |
7.4% |
| Dyspnoea |
5.6% |
| Vision Blurred |
5.6% |
| Device Malfunction |
3.7% |
| Drug Ineffective |
3.7% |
| Lung Neoplasm Malignant |
3.7% |
| Pneumonia |
3.7% |
| Sinusitis |
3.7% |
| Swollen Tongue |
3.7% |
| Urinary Retention |
3.7% |
| Urinary Tract Infection |
3.7% |
| Weight Increased |
3.7% |
| Wheezing |
3.7% |
| Drug Prescribing Error |
1.9% |
| Frequent Bowel Movements |
1.9% |
| Gastrointestinal Motility Disorder |
1.9% |
| Glossodynia |
1.9% |
| Hypertension |
1.9% |
|
| Secondary |
| Chronic Obstructive Pulmonary Disease |
22.6% |
| Hypertension |
16.4% |
| Supplementation Therapy |
6.9% |
| Emphysema |
6.3% |
| Anxiety |
5.7% |
| Asthma |
5.7% |
| Bronchitis Chronic |
5.7% |
| Cardiac Disorder |
3.8% |
| Atrial Fibrillation |
3.1% |
| Blood Cholesterol Increased |
3.1% |
| Gastrooesophageal Reflux Disease |
3.1% |
| Pain |
3.1% |
| Back Pain |
2.5% |
| Hypothyroidism |
2.5% |
| Abdominal Discomfort |
1.9% |
| Diabetes Mellitus |
1.9% |
| Prophylaxis |
1.9% |
| Anticoagulant Therapy |
1.3% |
| Aortic Valve Prolapse |
1.3% |
| Asbestosis |
1.3% |
|
| Incorrect Route Of Drug Administration |
16.7% |
| Product Quality Issue |
10.0% |
| Macular Degeneration |
6.7% |
| Oropharyngeal Pain |
6.7% |
| Sinusitis |
6.7% |
| Swollen Tongue |
6.7% |
| Dyspnoea |
3.3% |
| Frequent Bowel Movements |
3.3% |
| Lung Neoplasm Malignant |
3.3% |
| Skin Burning Sensation |
3.3% |
| Spinal Compression Fracture |
3.3% |
| Sputum Increased |
3.3% |
| Testicular Pain |
3.3% |
| Throat Irritation |
3.3% |
| Thrombocytopenia |
3.3% |
| Thyroid Disorder |
3.3% |
| Urinary Retention |
3.3% |
| Urinary Tract Infection |
3.3% |
| Weight Increased |
3.3% |
| Wheezing |
3.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
68.4% |
| Chronic Obstructive Pulmonary Disease |
3.9% |
| Pain |
3.4% |
| Drug Use For Unknown Indication |
3.0% |
| Dyspnoea |
3.0% |
| Asthma |
2.6% |
| Hepatitis C |
1.8% |
| Nausea |
1.7% |
| Rheumatoid Arthritis |
1.5% |
| Depression |
1.2% |
| Prophylaxis |
1.2% |
| Wheezing |
1.2% |
| Anxiety |
1.0% |
| Cough |
0.9% |
| Hypertension |
0.9% |
| Anticoagulant Therapy |
0.9% |
| Blood Pressure |
0.9% |
| Respiratory Tract Congestion |
0.9% |
| Atrial Fibrillation |
0.8% |
| Constipation |
0.8% |
|
| Pneumonia |
18.5% |
| Sinusitis |
7.7% |
| Chronic Obstructive Pulmonary Disease |
6.2% |
| Drug Ineffective |
6.2% |
| Rash |
6.2% |
| Wheezing |
6.2% |
| Fatigue |
4.6% |
| Respiratory Failure |
4.6% |
| Tremor |
4.6% |
| Weight Decreased |
4.6% |
| Atrial Fibrillation |
3.1% |
| Cough |
3.1% |
| Death |
3.1% |
| Diarrhoea |
3.1% |
| Dyspnoea |
3.1% |
| Inappropriate Schedule Of Drug Administration |
3.1% |
| Influenza |
3.1% |
| Lower Gastrointestinal Haemorrhage |
3.1% |
| Malignant Neoplasm Progression |
3.1% |
| Ocular Hyperaemia |
3.1% |
|
